Laurie Dolan

Dr. Laurie Dolan


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
LDLaurie Dolan
Laurie Dolan
AKAlice Raphael Karikachery
Alice Raphael Karikachery
VTVelaphi Thipe
Velaphi Thipe
BABenjamin G. Arceneaux
Benjamin G. Arceneaux
KKKavita Katti
Kavita Katti
ACAlton M Chesne
Alton M Chesne
TCN006, a formulation of (R)-3-Hydroxybutyrate glycerides, is a promising ingredient for enhancing ketone intake of humans. Ketones have been shown to have beneficial effects on human health. To be used by humans, TCN006 must be determined safe in appropriately designed safety studies. The results of a bacterial reverse mutation assay, an in vitro mammalian micronucleus study, and 14-and 90-day repeat dose toxicity studies in rats are reported herein. In the 14- and 90-day studies, male and female Wistar rats had free access to drinking water containing 0, 75,000, 125,000 or 200,000 ppm TCN006 for 92 and 93 days, respectively. TCN006 tested negative for genotoxicity and the no observed adverse effect level (NOAEL) for toxicity in the 14- and 90-day studies was 200,000 ppm, the highest dose administered. In the longer term study, the mean overall daily intake of TCN006 in the 200,000 ppm groups was 14,027.9 mg/kg bw/day for males and 20,507.0 mg/kg bw/day for females. At this concentration, palatability of water was likely affected, which led to a decrease in water consumption in both males and females compared to respective controls. This had no effect on the health of the animals. Although the rats were administered very high levels of (R)-3-Hydroxybutyrate glycerides, there were no signs of ketoacidosis.

31 July 2025 in Toxicology Reports
Verified
Journal Article
Open access
RGRit Gurung
Rit Gurung
LDLaurie Dolan
Laurie Dolan
BABenjamin G. Arceneaux
Benjamin G. Arceneaux
HGHiroe Go
Hiroe Go
EPEun Jung Park
Eun Jung Park
6′-Sialyllactose (6′-SL) sodium salt is the sodium salt of a naturally occurring trisaccharide found in dairy products and human milk. 6′-SL sodium salt formulations produced by different methods have been the subject of other safety studies and are approved for use in food in the United States and other countries. Because the manufacturing process can influence the toxicological profile of a substance, studies were undertaken to assess the safety of 6′-SL sodium salt produced by a novel manufacturing process. The results of genetic toxicity tests (bacterial reverse mutation assay, an in vitro mammalian chromosome aberration test, and an in vivo micronucleus test in mice), and acute and 26-week repeated dose oral toxicity studies in rats for this novel 6′-SL sodium salt are reported herein. All studies were conducted according to Good Laboratory Practice (GLP) and the respective guidelines from the Korean Ministry of Food and Drug Safety (MFDS). The substance showed no evidence of genotoxicity in all three assays that were conducted to address this endpoint and was not acutely toxic to rats at doses up to 6000 mg/kg body weight (bw). The no observed adverse effect level (NOAEL) for toxicity in the 26-week study in both male and female rats was 6000 mg/kg bw/day, the highest dose administered. This new 6′-SL sodium salt is safe in rats at a higher level and for a longer period of time than previously studied in either rats or pigs, demonstrating a more robust safety profile.